D
Diederick E. Grobbee
Researcher at Utrecht University
Publications - 1108
Citations - 136069
Diederick E. Grobbee is an academic researcher from Utrecht University. The author has contributed to research in topics: Population & Risk factor. The author has an hindex of 155, co-authored 1051 publications receiving 122748 citations. Previous affiliations of Diederick E. Grobbee include National Heart Foundation of Australia & Radboud University Nijmegen Medical Centre.
Papers
More filters
Journal ArticleDOI
The role of calcium supplementation in the treatment of hypertension. Current evidence.
TL;DR: The aim of this brief editorial is to review the evidence for a link between dietary calcium and hypertension from population studies, the blood pressure effects of calcium supplements in randomised, placebo-controlled trials, and the correlates of the putative antihypertensive response.
Journal ArticleDOI
The Dutch Vascular Factors in Dementia Study: rationale and design.
Fop van Kooten,Michiel L. Bots,Monique M.B. Breteler,Frits Haverkate,John C. van Swieten,Diederick E. Grobbee,Peter J. Koudstaal,Cornelis Kluft +7 more
TL;DR: The methods and baseline findings of a large study aimed at identifying potentially modifiable vascular, thrombogenic, and metabolic determinants of dementia are described, and the role of vascular factors in dementia, irrespective of its cause is investigated.
Journal ArticleDOI
High resolution annual average air pollution concentration maps for the Netherlands
Oliver Schmitz,Rob Beelen,Maciej Strak,Gerard Hoek,Ivan Soenario,Bert Brunekreef,Ilonca Vaartjes,Martin Dijst,Diederick E. Grobbee,Derek Karssenberg +9 more
TL;DR: High-resolution datasets for the Netherlands providing average ambient air pollution concentration values for the year 2009 are presented, allowing for spatial aggregations on different scales, nationwide individual exposure assessment, and the integration of activity patterns in the exposure estimation of individuals.
Journal ArticleDOI
Oral testosterone supplementation and chronic low-grade inflammation in elderly men: a 26-week randomized, placebo-controlled trial.
H R Nakhai-Pour,Diederick E. Grobbee,Marielle H. Emmelot-Vonk,Michiel L. Bots,Harald J. J. Verhaar,Yvonne T. van der Schouw +5 more
TL;DR: Oral testosterone undecanoate supplementation, in dosage of 160 mg daily for 26 weeks, does not increase hs-CRP levels in elderly men.
Journal ArticleDOI
Statin Treatment and Progression of Atherosclerotic Plaque Burden
TL;DR: Given that the effects of statins on atherosclerosis progression are evident even in normocholesterolaemic patients at increased risk of developing CHD, early intervention with statin therapy may be effective in preventingCHD, irrespective of lipid level.